Results

Total Results: 60 records

Showing results for "lmwh prophylaxis".

1. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/thromboembolism-update/research-2017
   June 22, 2017 - Initiated Feb. 17, 2016 Research Protocol Jun. 22, 2017 Systematic Review Venous Thromboembolism Prophylaxis … Most studies evaluated low molecular weight heparin (LMWH), not low-risk interventions (such as aspirin … For THR: low molecular weight heparin (LMWH) has lower risk than unfractionated heparin (UFH) of various … Conclusions VTE prophylaxis after major orthopedic surgery trades off lowered VTE risk with possible … Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update.

2. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
   June 01, 2017 - Most studies evaluated low molecular weight heparin (LMWH), not low- risk interventions (such as aspirin … agents within the defined classes of antiplatelet agents, low molecular weight heparin (LMWH), unfractionated … = low molecular weight heparin, OR = odds ratio, RCT = randomized controlled trials, VKA = vitamin … = low molecular weight heparin, OR = odds ratio, PE = pulmonary embolism, RCT = randomized controlled … = low molecular weight heparin, OR = odds ratio, RCT = randomized controlled trials.

3. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
   June 01, 2017 - Most studies evaluated low molecular weight heparin (LMWH), not low- risk interventions (such as aspirin … agents within the defined classes of antiplatelet agents, low molecular weight heparin (LMWH), unfractionated … = low molecular weight heparin, OR = odds ratio, RCT = randomized controlled trials, VKA = vitamin … = low molecular weight heparin, OR = odds ratio, PE = pulmonary embolism, RCT = randomized controlled … = low molecular weight heparin, OR = odds ratio, RCT = randomized controlled trials.

4. Appendix B: Risk Assessment Models, Protocols, and Order Sets | Agency for Healthcare Research and Quality
   www.ahrq.gov/patient-safety/settings/hospital/vtguide/appb.html
   October 01, 2022 - Key: UFH = unfractionated heparin; LMWH = low molecular weight heparin; SubQ = subcutaneous. … Key:  UFH = unfractionated heparin; LMWH = low molecular weight heparin; SubQ = subcutaneous. … For example, patients at risk would be offered low molecular weight heparin or unfractionated heparin … For example, patients at risk would be offered low molecular weight heparin or unfractionated heparin … COPD = chronic obstructive pulmonary disease; VTE = venous thromboembolism; LMWH = low molecular weight

5. Appendix B: Risk Assessment Models, Protocols, and Order Sets | Agency for Healthcare Research and Quality
   www.ahrq.gov/es/patient-safety/settings/hospital/vtguide/appb.html
   October 01, 2022 - Key: UFH = unfractionated heparin; LMWH = low molecular weight heparin; SubQ = subcutaneous. … Key:  UFH = unfractionated heparin; LMWH = low molecular weight heparin; SubQ = subcutaneous. … For example, patients at risk would be offered low molecular weight heparin or unfractionated heparin … For example, patients at risk would be offered low molecular weight heparin or unfractionated heparin … COPD = chronic obstructive pulmonary disease; VTE = venous thromboembolism; LMWH = low molecular weight

6. Appendix B: Risk Assessment Models, Protocols, and Order Sets | Agency for Healthcare Research and Quality
   www.ahrq.gov/patient-safety/resources/vtguide/appb.html
   May 01, 2016 - Key: UFH = unfractionated heparin; LMWH = low molecular weight heparin; SubQ = subcutaneous. … Key:  UFH = unfractionated heparin; LMWH = low molecular weight heparin; SubQ = subcutaneous. … For example, patients at risk would be offered low molecular weight heparin or unfractionated heparin … For example, patients at risk would be offered low molecular weight heparin or unfractionated heparin … COPD = chronic obstructive pulmonary disease; VTE = venous thromboembolism; LMWH = low molecular weight

7. Appendix B: Risk Assessment Models, Protocols, and Order Sets | Agency for Healthcare Research and Quality
   ce.effectivehealthcare.ahrq.gov/patient-safety/settings/hospital/vtguide/appb.html
   October 01, 2022 - Key: UFH = unfractionated heparin; LMWH = low molecular weight heparin; SubQ = subcutaneous. … Key:  UFH = unfractionated heparin; LMWH = low molecular weight heparin; SubQ = subcutaneous. … For example, patients at risk would be offered low molecular weight heparin or unfractionated heparin … For example, patients at risk would be offered low molecular weight heparin or unfractionated heparin … COPD = chronic obstructive pulmonary disease; VTE = venous thromboembolism; LMWH = low molecular weight

8. Blood-Clots-Hip-Knee-Surgery Executive (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_executive.pdf
   March 01, 2012 - Finally, when LMWH agents were compared versus mechanical prophylaxis, the only significant difference … The balance of benefits and harms from using enoxaparin versus another low molecular weight heparin … = low molecular weight heparin; M = moderate; NNH = number needed to harm; NNT = number needed to … information for an additional between class comparison (oral direct factor Xa inhibitor versus injectable low … molecular weight heparin) in KQ 5.

9. Around the Block | PSNet
   psnet.ahrq.gov/web-mm/around-block
   July 01, 2018 - surgeon, recognizing the risk of deep vein thrombosis (DVT), prescribed enoxaparin (Lovenox) for DVT prophylaxis … The Commentary In this case, a patient received low molecular-weight heparin (LMWH) around the time … For instance, should this patient have received pharmacologic DVT prophylaxis at all? … Although intermittent pneumatic compression devices are an alternative to pharmacologic prophylaxis, … Low molecular weight heparin and neuraxial anesthesia.

10. Chapter 3. Outline the Evidence and Identify Best Practices | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/resources/vtguide/guide3.html
    February 01, 2016 - in the form of low-molecular-weight heparin (LMWH), low-dose unfractionated heparin (UFH) (5,000 units … In AT9, pharmacologic prophylaxis with UFH or LMWH or mechanical prophylaxis are deemed acceptable … as the preferred choice for this indication and stipulates that LMWH likely has greater efficacy. … Either UFH or LMWH are recommended for patients with malignancy undergoing major surgical intervention … or ASA for lower risk patients, or with LMWH for higher risk patients.

11. Chapter 3. Outline the Evidence and Identify Best Practices | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/hospital/vtguide/guide3.html
    February 01, 2016 - in the form of low-molecular-weight heparin (LMWH), low-dose unfractionated heparin (UFH) (5,000 units … In AT9, pharmacologic prophylaxis with UFH or LMWH or mechanical prophylaxis are deemed acceptable … as the preferred choice for this indication and stipulates that LMWH likely has greater efficacy. … Either UFH or LMWH are recommended for patients with malignancy undergoing major surgical intervention … or ASA for lower risk patients, or with LMWH for higher risk patients.

12. Chapter 3. Outline the Evidence and Identify Best Practices | Agency for Healthcare Research and Quality
    www.ahrq.gov/es/patient-safety/settings/hospital/vtguide/guide3.html
    February 01, 2016 - in the form of low-molecular-weight heparin (LMWH), low-dose unfractionated heparin (UFH) (5,000 units … In AT9, pharmacologic prophylaxis with UFH or LMWH or mechanical prophylaxis are deemed acceptable … as the preferred choice for this indication and stipulates that LMWH likely has greater efficacy. … Either UFH or LMWH are recommended for patients with malignancy undergoing major surgical intervention … or ASA for lower risk patients, or with LMWH for higher risk patients.

13. Making Healthcare Safer Practices: 16. Venous Thromboembolism (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/venous-thromboembolism-1.pdf
    March 01, 2020 - Further, ACCP recommends low molecular weight heparin (LMWH) over other pharmacologic prophylaxis agents … Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total … Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis … The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement … molecular weight heparin (LMWH) following elective THA, patients were randomly assigned to an

14. Making Healthcare Safer Practices: 16. Venous Thromboembolism (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/venous-thromboembolism-1.pdf
    March 01, 2020 - Further, ACCP recommends low molecular weight heparin (LMWH) over other pharmacologic prophylaxis agents … Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total … Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis … The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement … molecular weight heparin (LMWH) following elective THA, patients were randomly assigned to an

15. Chapter 3. Outline the Evidence and Identify Best Practices | Agency for Healthcare Research and Quality
    ce.effectivehealthcare.ahrq.gov/patient-safety/settings/hospital/vtguide/guide3.html
    February 01, 2016 - in the form of low-molecular-weight heparin (LMWH), low-dose unfractionated heparin (UFH) (5,000 units … In AT9, pharmacologic prophylaxis with UFH or LMWH or mechanical prophylaxis are deemed acceptable … as the preferred choice for this indication and stipulates that LMWH likely has greater efficacy. … Either UFH or LMWH are recommended for patients with malignancy undergoing major surgical intervention … or ASA for lower risk patients, or with LMWH for higher risk patients.

16. Chapter 4. Choose the Model To Assess VTE and Bleeding Risk | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/hospital/vtguide/guide4.html
    October 01, 2022 - ) 40 mg SubQ q day __ LMWH (Enoxaparin) 30 mg SubQ q 12 hours __ No Prophylaxis, Ambulate __ Other … Key: UFH = unfractionated heparin; SubQ = subcutaneous; LMWH = low-molecular-weight heparin. … UFH or LMWH prophylaxis * High Risk: Hip or knee arthroplasty, hip fracture surgery, multiple major … UFH or LMWH prophylaxis * High Risk: Hip or knee arthroplasty, hip fracture surgery, multiple major … . 1 IPC = intermittent pneumatic compression LMWH = low-molecular-weight heparin UFH = unfractionated

17. Chapter 4. Choose the Model To Assess VTE and Bleeding Risk | Agency for Healthcare Research and Quality
    www.ahrq.gov/es/patient-safety/settings/hospital/vtguide/guide4.html
    October 01, 2022 - ) 40 mg SubQ q day __ LMWH (Enoxaparin) 30 mg SubQ q 12 hours __ No Prophylaxis, Ambulate __ Other … Key: UFH = unfractionated heparin; SubQ = subcutaneous; LMWH = low-molecular-weight heparin. … UFH or LMWH prophylaxis * High Risk: Hip or knee arthroplasty, hip fracture surgery, multiple major … UFH or LMWH prophylaxis * High Risk: Hip or knee arthroplasty, hip fracture surgery, multiple major … . 1 IPC = intermittent pneumatic compression LMWH = low-molecular-weight heparin UFH = unfractionated

18. Chapter 4. Choose the Model To Assess VTE and Bleeding Risk | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/resources/vtguide/guide4.html
    May 01, 2016 - ) 40 mg SubQ q day __ LMWH (Enoxaparin) 30 mg SubQ q 12 hours __ No Prophylaxis, Ambulate __ Other … Key: UFH = unfractionated heparin; SubQ = subcutaneous; LMWH = low-molecular-weight heparin. … UFH or LMWH prophylaxis * High Risk: Hip or knee arthroplasty, hip fracture surgery, multiple major … UFH or LMWH prophylaxis * High Risk: Hip or knee arthroplasty, hip fracture surgery, multiple major … . 1 IPC = intermittent pneumatic compression LMWH = low-molecular-weight heparin UFH = unfractionated

19. Chapter 4. Choose the Model To Assess VTE and Bleeding Risk | Agency for Healthcare Research and Quality
    www.qualitymeasures.ahrq.gov/patient-safety/settings/hospital/vtguide/guide4.html
    October 01, 2022 - Key: UFH = unfractionated heparin; SubQ = subcutaneous; LMWH = low-molecular-weight heparin. … UFH or LMWH prophylaxis * High Risk: Hip or knee arthroplasty, hip fracture surgery, multiple major … UFH or LMWH prophylaxis * High Risk: Hip or knee arthroplasty, hip fracture surgery, multiple major … Prophylaxis 0-2 Very low-low <1.5% 1 Early ambulation, IPC 3-4 Moderate 3% 1 LMWH; UFH … . 1 IPC = intermittent pneumatic compression LMWH = low-molecular-weight heparin UFH = unfractionated

20. Chapter 4. Choose the Model To Assess VTE and Bleeding Risk | Agency for Healthcare Research and Quality
    ce.effectivehealthcare.ahrq.gov/patient-safety/settings/hospital/vtguide/guide4.html
    October 01, 2022 - Key: UFH = unfractionated heparin; SubQ = subcutaneous; LMWH = low-molecular-weight heparin. … UFH or LMWH prophylaxis * High Risk: Hip or knee arthroplasty, hip fracture surgery, multiple major … UFH or LMWH prophylaxis * High Risk: Hip or knee arthroplasty, hip fracture surgery, multiple major … Prophylaxis 0-2 Very low-low <1.5% 1 Early ambulation, IPC 3-4 Moderate 3% 1 LMWH; UFH … . 1 IPC = intermittent pneumatic compression LMWH = low-molecular-weight heparin UFH = unfractionated